Spinal Cord Incentive Market to reach USD 4.12 billion at 8.0% CAGR by 2027; The introduction of other non-opioid medications into the market is increasing, reports Fortune Business Insights ™

Pune, India, January 18, 2021 (GLOBE NEWSWIRE) – The global backbone stimulation market it is expected to reach USD 4.12 billion by 2027, displaying a CAGR of 8.0% in the forecast period. Adopting such minimally invasive treatments can have a major impact on the global market, Fortune Business Insights says in a report. The market size was USD 2.88 billion in 2019.

Favorable Government guidance to boost market

The favorable policies of spinal stimulant therapy are expected to strengthen the healthy growth of the market. A number of government associations are introducing guidelines for the treatment of chronic pain and other disease symptoms, which, in turn, will help expand the market.

Request a copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spinal-cord-stimulation-market-100313

For example, in January 2019, the National Institute for Health and Care Excellence published guidelines and recommendations for the Senza SCS system, which provides HF10 therapy to treat patients with neuropathic pain. In addition, the rising trend toward other non-opioid therapies coupled with high demand for spinal stimulation will soon boost the market. For example, in 2018, the FDA received more than 200 applications from companies seeking a speedy approval process for devices that can be used instead of opioids for pain management.

We are making endless efforts to build businesses in this vital hourly need. Our knowledge and experience can provide great benefits to help recover from this global pandemic.

Re-registration of effective surgeries to block the market among COVID-19

Delays in selective and non-urgent studies by the government to administer COVID-19 patients have impacted on market growth. According to COVIDSurg, approximately 28.4 million surgeries were canceled or postponed at a maximum of 12 weeks of disruption due to COVID – 19. Many companies operating in the market reported a sharp drop in income at the time of the pandemic.

Click here for the short-term and long-term effects of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/spinal-cord-stimulation-market-100313

For example, the Abbott neuromodulation division reported a 30.1% decline in global revenue in the first quarter of 2020 compared to the same period in 2019. Similarly, the neuromodulation division of Boston Scientific Corporation saw a decline of 24.6% in global sales in the first six months of 2020 compared to the same period in 2019.

Illness of Disc diseases to increase growth in Europe

North America accounted for the largest share of the primary market due to the rapid adoption of neuromodulation therapies. The market in Europe is expected to grow due to the rising incidence of degenerative disc diseases and chronic pain. The introduction of innovative systems by companies will allow a rapid expansion of the market in the sector.

For example, in January 2019, the Spectra WaveWriter spinal cord stimulation system was launched by Boston Scientific in Europe. Asia Pacific is likely to account for a lot in the global market during the expected period. The growth is due to the rapid adoption of neuromodulation therapies. The critical geriatric population is expected to rise well for the Asia Pacific market. The growing demand for less aggressive treatments will stimulate the development of the market in the region.

Buy Quick – Spinal Cord Incentive Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100313

Key Development:

September 2018: Nevro, a medical device company, has announced that it has secured TGA approval for Senza II, a second-generation spinal stimulation system.

The report lists the key companies in the Global Spinal Cord Injury Market:

  • Boston Scientific Corporation (Massachusetts, SA)
  • Medtronic (Dublin, Ireland)
  • Abbott (Illinois, SA)
  • Corp Nevro (California, SA)
  • Nuvectra (Texas, SA)
  • Stimwave LLC (Florida, SA)
  • Other prominent players

Do you have any questions? Ask our experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/spinal-cord-stimulation-market-100313

Contents:

  • Introduction
    • Scope of research
    • Market view
    • Research Methodology
    • Explanations and assumptions
  • Government Minutes
  • Market dynamics
    • Market drivers
    • Market barriers
    • Market opportunities
  • Key views
    • Frequency of key indicators – for key countries / regions
    • The regulatory situation – for key countries / regions
    • Impact of COVID-19 on Global Spinal Cord Stimulation Market
    • Launch of new product
    • Key Business Developments – Mergers, Acquisitions and Partnerships
  • Global Spinal Cord Stimulation Market Analysis, Outlook and Outlook, 2016-2027
    • Main Findings / Summary
    • Market analysis, vision and forecast – by product
      • Rechargeable
      • Non-reinvestment
    • Market analysis, vision and forecast – according to disease signal
      • Failed Surgery Syndrome (FBSS)
      • Degenerative disc disease (DDD)
      • Complex Regional Pain Syndrome (CRPS)
      • Arachnoiditis
      • Others
    • Market analysis, insight and foresight – By the end user
      • Ospadalan
      • Ambulance Centers
      • Specialty Clinics
    • Market analysis, vision and forecast – by region
      • North America
      • Europe
      • Asia Pacific
      • Rest of the world

TOC continues….!

Get Your Custom Search Report: https://www.fortunebusinessinsights.com/enquiry/customization/spinal-cord-stimulation-market-100313

A SECOND RESEARCH IS CARRIED OUT FOR THE FOLLOWING INFORMATION:

  • Details such as revenue, market share, strategies, growth rate, output & prices by region / country for all major companies
  • Details of frequency, frequency, patient numbers, patient circulation, average price of treatment, etc.
  • Number of end-user facilities by region / country and average annual consumption or supply of equipment by type of end-user facility
  • Number of procedures and average price of procedures
  • Replacement rate and capital equipment prices
  • Market dynamics regarding the market under focus – Drivers, restrictions, trends, and opportunities
  • Market & technology trends, new product developments, product pipeline.

View related reports:

Smart Information Lenses Market Share & Business Analysis, by Type (Continuous Intraocular Pressure Study Lessons, Photochromic Lessons, and Others), By End User (Ophthalmology Clinics, Home Care, and Others), and Regional Outlook, 2019-2026

Veterinary vaccine vaccine market share Analysis & Industry, by Type (Alum and Calcium Salts, Oil Emulsion Oil, Liposomes, and Archaeosomes, Nanoparticles and Mi-croparticles, and others), by Application (Research, and Commercial), By Route of Administration ( Oral, Subcutaneous, Intramuscular, and others), by animal type (livestock, and companion) and regional forecast, 2020-2027

Lymphoma Treatment Market Share & Business Analysis, By Treatment (Immunotherapy, Targeted Medicine, Chemotherapy, and others), by disease type (non-Hodgkin lymphoma, and Hodgkin lymphoma), by circulation channel (hospital pharmacies, mini pharmacies) -sale, online pharmacies, and others), and Regional Weather, 2019-2026

Neonatal intensive care unit market share Analysis & Industry, by Product (Neonatal Incubators, Neonatal Phototherapy Equipment, Neonatal Ventilators, Neonatal Monitor, and others), By end user (hospitals, and specialty clinics), and regional forecast, 2020-2027

Healthcare Fund Management Market Share & Business Analysis, By Product (Radiofrequency Identification (RFID), Real Time Positioning Systems (RTLS), and others), By Demand (Staff Management, Equipment Management, Patient Monitoring, and Supply Chain Management), By End User (Hospitals, Laboratories, etc.) and Regional Outlook, 2020-2027

About:

Fortune Business Insights ™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We design innovative solutions for our clients, helping them to meet challenges specific to their businesses. Our goal is to empower our clients with complete market information, providing an overview of the market in which they operate.

Our reports contain a unique combination of visual insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and methods to compile comprehensive market analyzes, with relevant data in place.

At Fortune Business Insights ™ we aim to highlight the most beneficial growth opportunities for our clients. We therefore offer recommendations, making it easier for them to move through technological and market – related changes. Our advisory services are designed to help organizations identify hidden opportunities and understand key competitive challenges.

Contact us:

Fortune Business Insights ™ Pvt. Limited.
308, Head Office,
Survey No. 36, Banner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US: +1 424 253 0390
RA: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]
Fortune Business Insights ™
LinkedIn | Twitter | Blogs

Press release: https://www.fortunebusinessinsights.com/press-release/spinal-cord-stimulation-market-9101

.Source